PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.\', \'Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.\', \'NewDrug, P.C., Patras Science Park, 26504 Patras, Greece.\', \'Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.\', \'Department of Chemistry, National and Kapodistrian University of Athens, Zographou, 15784 Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 61810.3390/molecules26030618
?:hasPublicationType
?:journal
  • Molecules (Basel, Switzerland)
is ?:pmid of
?:pmid
?:pmid
  • 33504092
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33504092>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33504092>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all